Fluorouracil Treatment Via Colon for Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 16, 2024

Primary Completion Date

May 1, 2028

Study Completion Date

May 1, 2029

Conditions
Colorectal Cancer
Interventions
DRUG

Colonic local administration of fluorouracil with enhanced adhesion

Fluorouracil is administered via the colon as an injectable solution at a dose of 500 mg per day for 6 days, along with poloxamer 407 and poloxamer 188 used as thermosensitive hydrogel to enhance adhesion.

Trial Locations (1)

210011

RECRUITING

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The Second Hospital of Nanjing Medical University

OTHER